CFDE Data Portal | Search GGTLC4P

	Label	Description
	GGTLC4P Gene (Entity type)	ENSG00000230712 - gamma-glutamyltransferase light chain 4 pseudogene
	GSE146982 metformin 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 11 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE115395 enzalutamide LNCaP 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE174745 dopamine neuron 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE207410 GSE207411 ARID1A knockdown 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Ovary 20-29 vs 40-49 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Testis 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Vagina 20-29 vs 60-69 Up Gene Set (Entity type)	A Gene Set from GTEx

GGTLC4P

ENSG00000230712 - gamma-glutamyltransferase light chain 4 pseudogene

GSE146982 metformin 4 v 5 human dn

A Gene Set from LINCS

GSE252944 AKT inhibition 11 v 4 human up

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 8 human up

A Gene Set from LINCS

GSE115395 enzalutamide LNCaP 2 v 3 human up

A Gene Set from LINCS

GSE174745 dopamine neuron 1 v 3 human up

A Gene Set from LINCS

GSE207410 GSE207411 ARID1A knockdown 2 v 4 human up

A Gene Set from LINCS

GTEx Ovary 20-29 vs 40-49 Up

A Gene Set from GTEx

GTEx Testis 20-29 vs 70-79 Down

A Gene Set from GTEx

GTEx Vagina 20-29 vs 60-69 Up

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.